The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer

BACKGROUND: There is limited evidence relating to the cost-effectiveness of treatments for localised prostate cancer. METHODS: The cost-effectiveness of active monitoring, surgery, and radiotherapy was evaluated within the Prostate Testing for Cancer and Treatment (ProtecT) randomised controlled tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Noble, Sian M., Garfield, Kirsty, Lane, J. Athene, Metcalfe, Chris, Davis, Michael, Walsh, Eleanor I., Martin, Richard M., Turner, Emma L., Peters, Tim J., Thorn, Joanna C., Mason, Malcolm, Bollina, Prasad, Catto, James W. F., Doherty, Alan, Gnanapragasam, Vincent, Hughes, Owen, Kockelbergh, Roger, Kynaston, Howard, Paul, Alan, Paez, Edgar, Rosario, Derek J., Rowe, Edward, Oxley, Jon, Staffurth, John, Neal, David E., Hamdy, Freddie C., Donovan, Jenny L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524753/
https://www.ncbi.nlm.nih.gov/pubmed/32669672
http://dx.doi.org/10.1038/s41416-020-0978-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524753/
https://www.ncbi.nlm.nih.gov/pubmed/32669672
http://dx.doi.org/10.1038/s41416-020-0978-4

Ejemplares similares